Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

GLP-1s have gone so far as to disrupt the food, clothing, and, of course, weight-loss industries. Yet despite the ubiquitousness of injectable drugs indicated for people with obesity—such as Wegovy ...

For example, Saxenda (liraglutide), which has the same active drug as Victoza, is used for weight loss in people with ... The following chart lists examples of mild side effects that can most ...

A dad died just days after using a weight-loss jab so he could ‘confidently walk his daughter down the aisle’, and now his family are demanding answers. Back in 2022, Tim Ramsay decided he wanted to ...

Saxenda is an older drug of the same GLP-1 drug class as the Danish company’s popular Ozempic diabetes treatment and Wegovy weight-loss medication. In an interview with the Financial Times ...

Saxenda is an older drug of the same GLP-1 drug class as the company’s popular Ozempic diabetes treatment and Wegovy weight loss medication. Biocon chief executive officer Siddharth Mittal ...

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.